▶ 調査レポート

世界の勃起不全薬市場:動向・競争分析

• 英文タイトル:Global Erectile Dysfunction Drugs Industry Research Report, Growth Trends and Competitive Analysis 2019-2025

QYResearchが調査・発行した産業分析レポートです。世界の勃起不全薬市場:動向・競争分析 / Global Erectile Dysfunction Drugs Industry Research Report, Growth Trends and Competitive Analysis 2019-2025 / QYR9ST15298資料のイメージです。• レポートコード:QYR9ST15298
• 出版社/出版日:QYResearch / 2019年9月10日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、113ページ
• 納品方法:Eメール(受注後2-3営業日)
• 産業分類:医薬品・医療
• 販売価格(消費税別)
  Single User¥725,200 (USD4,900)▷ お問い合わせ
  Enterprise License¥1,450,400 (USD9,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
※本調査レポートでは、世界の勃起不全薬市場について調査・分析し、市場規模、市場動向、市場予測(~2025年)、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。勃起不全薬の種類別には、シルデナフィル、タダラフィル、その他に、用途別には、病院薬局、プライベートクリニック、小売薬局、Eコマース(B2B)、Eコマース(B2C)に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。

・調査レポートの概要
・グローバル成長傾向・産業動向
・企業別市場シェア
・勃起不全薬の種類別市場規模:シルデナフィル、タダラフィル、その他
・勃起不全薬の用途別市場規模:病院薬局、プライベートクリニック、小売薬局、Eコマース(B2B)、Eコマース(B2C)
・勃起不全薬の地域別市場規模:北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ
・主要企業のプロフィール:Eli Lilly、Pfizer、Bayer、BaiYunShan General Factory、S.K. Chemicals、Teva Pharma、Dong-A ST、Metuchen Pharma、Seoul Pharma、CSBIO.
・市場規模予測2019-2025:生産量
・市場規模予測2019-2025:消費量
・バリューチェーン・販売チャネル分析
・市場機会・課題分析
...

Erectile dysfunction (ED), also known as impotence, is a type of sexual dysfunction characterized by the inability to develop or maintain an erection of the penis during sexual activity. Erectile dysfunction can have psychological consequences as it can be tied to relationship difficulties and self-image.The classification of Erectile Dysfunction Drugs includes Sildenafil, Tadalafil and others, and the proportion of Sildenafil in 2018 is about 99.85%, and the proportion is in decreasing trend from 2014 to 2018.Erectile Dysfunction Drugs is widely used through Hospital Pharmacies, Private Clinics, Retail Pharmacies, E-Commerce (B2B) and E-Commerce (B2C). The most proportion of Erectile Dysfunction Drugs is used for Hospital Pharmacies, and the sales proportion in 2018 is 29.24%.North America is the largest consumption place, with a consumption market share nearly 39.05% in 2018. Following North America, Europe is the second largest consumption place with the consumption market share of 30.52%. Despite of increasing demand for erectile dysfunction drugs, this market is going to experience a decline in forecast period due to patent expiration of major brands. On the contrary, it will provide the key opportunity for generic manufacturers to enter the market. Generic drugs are the promising opportunity for this market.
In 2018, the global Erectile Dysfunction Drugs market size was 5042.6 million US$ and is forecast to 6583.3 million US in 2025, growing at a CAGR of 6.0% from 2019. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Erectile Dysfunction Drugs.

This study researches the market size of Erectile Dysfunction Drugs, presents the global Erectile Dysfunction Drugs sales and revenue by companies, regions, type and application, history breakdown data from 2014 to 2019, and forecast to 2025.
This report focuses on the key data information of Erectile Dysfunction Drugs in key regions like North America, Europe, China, South Korea and Israel, presents sales, revenue, market share, growth rate of Erectile Dysfunction Drugs for each region and countries in each region.
For top companies, this report investigates and analyzes the sales, revenue, market share and growth rate for the top players, key data from 2014 to 2019.
This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter’s Five Forces Analysis.

This report includes the following manufacturers; we can also add the other companies as you want.
Pfizer
Bayer
BaiYunShan General Factory
S.K. Chemicals
Teva Pharma
Dong-A ST
Metuchen Pharma
Seoul Pharma
CSBIO.

Market Segment by Product Type
Sildenafil
Tadalafil
Others

In 2018, Sildenafil accounted for a major share of 56% in the global Erectile Dysfunction Drugs market. And this product segment is poised to reach 3366.84 M USD by 2025 from 2483.77 M USD in 2019.

Market Segment by Application
Hospital Pharmacies
Private Clinics
Retail Pharmacies
E-Commerce (B2B)
E-Commerce (B2C)

In Erectile Dysfunction Drugs market, Hospital Pharmacies segment holds an important share in terms of application, and it is expected to reach a volume of 458.57 (M Pill) by 2025, at a CAGR of 12.63% during 2018 and 2025. It means that Erectile Dysfunction Drugs will be promising in the Hospital Pharmacies field in the next couple of years.

Market size split by Region
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa

The study objectives are:
To analyze and research the global Erectile Dysfunction Drugs status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Erectile Dysfunction Drugs manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Erectile Dysfunction Drugs are as follows:
History Year: 2014-2019
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

レポート目次

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Erectile Dysfunction Drugs Market Size Growth Rate by Type
1.3.2 Sildenafil
1.3.3 Tadalafil
1.3.4 Others
1.4 Market Segment by Application
1.4.1 Global Erectile Dysfunction Drugs Market Share by Application (2019-2025)
1.4.2 Hospital Pharmacies
1.4.3 Private Clinics
1.4.4 Retail Pharmacies
1.4.5 E-Commerce (B2B)
1.4.6 E-Commerce (B2C)
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Erectile Dysfunction Drugs Market Size
2.1.1 Global Erectile Dysfunction Drugs Revenue 2014-2025
2.1.2 Global Erectile Dysfunction Drugs Sales 2014-2025
2.2 Erectile Dysfunction Drugs Growth Rate by Regions
2.2.1 Global Erectile Dysfunction Drugs Sales by Regions 2014-2019
2.2.2 Global Erectile Dysfunction Drugs Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers

3 Market Share by Manufacturers
3.1 Erectile Dysfunction Drugs Sales by Manufacturers
3.1.1 Erectile Dysfunction Drugs Sales by Manufacturers 2014-2019
3.1.2 Erectile Dysfunction Drugs Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Erectile Dysfunction Drugs Revenue by Manufacturers (2014-2019)
3.2.2 Erectile Dysfunction Drugs Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Erectile Dysfunction Drugs Market Concentration Ratio (CR5 and HHI)
3.3 Erectile Dysfunction Drugs Price by Manufacturers
3.4 Key Manufacturers Erectile Dysfunction Drugs Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Erectile Dysfunction Drugs Market
3.6 Key Manufacturers Erectile Dysfunction Drugs Product Offered
3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Sildenafil Sales and Revenue (2014-2019)
4.1.2 Tadalafil Sales and Revenue (2014-2019)
4.1.3 Others Sales and Revenue (2014-2019)
4.2 Global Erectile Dysfunction Drugs Sales Market Share by Type
4.3 Global Erectile Dysfunction Drugs Revenue Market Share by Type
4.4 Erectile Dysfunction Drugs Price by Type

5 Market Size by Application
5.1 Overview
5.1 Global Erectile Dysfunction Drugs Sales by Application

6 North America
6.1 North America Erectile Dysfunction Drugs Breakdown Data by Company
6.2 North America Erectile Dysfunction Drugs Breakdown Data by Type
6.3 North America Erectile Dysfunction Drugs Breakdown Data by Application
6.4 North America Erectile Dysfunction Drugs Breakdown Data by Countries
6.4.1 North America Erectile Dysfunction Drugs Sales by Countries
6.4.2 North America Erectile Dysfunction Drugs Revenue by Countries
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico

7 Europe
7.1 Europe Erectile Dysfunction Drugs Breakdown Data by Company
7.2 Europe Erectile Dysfunction Drugs Breakdown Data by Type
7.3 Europe Erectile Dysfunction Drugs Breakdown Data by Application
7.4 Europe Erectile Dysfunction Drugs Breakdown Data by Countries
7.4.1 Europe Erectile Dysfunction Drugs Sales by Countries
7.4.2 Europe Erectile Dysfunction Drugs Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 UK
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Erectile Dysfunction Drugs Breakdown Data by Company
8.2 Asia Pacific Erectile Dysfunction Drugs Breakdown Data by Type
8.3 Asia Pacific Erectile Dysfunction Drugs Breakdown Data by Application
8.4 Asia Pacific Erectile Dysfunction Drugs Breakdown Data by Regions
8.4.1 Asia Pacific Erectile Dysfunction Drugs Sales by Countries
8.4.2 Asia Pacific Erectile Dysfunction Drugs Revenue by Countries
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Indonesia
8.4.9 Thailand
8.4.10 Malaysia
8.4.11 Philippines
8.4.12 Vietnam

9 Central & South America
9.1 Central & South America Erectile Dysfunction Drugs Breakdown Data by Company
9.2 Central & South America Erectile Dysfunction Drugs Breakdown Data by Type
9.3 Central & South America Erectile Dysfunction Drugs Breakdown Data by Application
9.4 Central & South America Erectile Dysfunction Drugs Breakdown Data by Countries
9.4.1 Central & South America Erectile Dysfunction Drugs Sales by Countries
9.4.2 Central & South America Erectile Dysfunction Drugs Revenue by Countries
9.4.3 Brazil

10 Middle East and Africa
10.1 Middle East and Africa Erectile Dysfunction Drugs Breakdown Data by Type
10.2 Middle East and Africa Erectile Dysfunction Drugs Breakdown Data by Application
10.3 Middle East and Africa Erectile Dysfunction Drugs Breakdown Data by Countries
10.3.1 Middle East and Africa Erectile Dysfunction Drugs Sales by Countries
10.3.2 Middle East and Africa Erectile Dysfunction Drugs Revenue by Countries
10.3.3 Turkey
10.3.4 GCC Countries
10.3.5 Egypt
10.3.6 South Africa

11 Company Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Details
11.1.2 Company Description and Business Overview
11.1.3 Sales, Revenue and Market Share of Erectile Dysfunction Drugs
11.1.4 Erectile Dysfunction Drugs Product Introduction
11.1.5 Eli Lilly Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Company Description and Business Overview
11.2.3 Sales, Revenue and Market Share of Erectile Dysfunction Drugs
11.2.4 Erectile Dysfunction Drugs Product Introduction
11.2.5 Pfizer Recent Development
11.3 Bayer
11.3.1 Bayer Company Details
11.3.2 Company Description and Business Overview
11.3.3 Sales, Revenue and Market Share of Erectile Dysfunction Drugs
11.3.4 Erectile Dysfunction Drugs Product Introduction
11.3.5 Bayer Recent Development
11.4 BaiYunShan General Factory
11.4.1 BaiYunShan General Factory Company Details
11.4.2 Company Description and Business Overview
11.4.3 Sales, Revenue and Market Share of Erectile Dysfunction Drugs
11.4.4 Erectile Dysfunction Drugs Product Introduction
11.4.5 BaiYunShan General Factory Recent Development
11.5 S.K. Chemicals
11.5.1 S.K. Chemicals Company Details
11.5.2 Company Description and Business Overview
11.5.3 Sales, Revenue and Market Share of Erectile Dysfunction Drugs
11.5.4 Erectile Dysfunction Drugs Product Introduction
11.5.5 S.K. Chemicals Recent Development
11.6 Teva Pharma
11.6.1 Teva Pharma Company Details
11.6.2 Company Description and Business Overview
11.6.3 Sales, Revenue and Market Share of Erectile Dysfunction Drugs
11.6.4 Erectile Dysfunction Drugs Product Introduction
11.6.5 Teva Pharma Recent Development
11.7 Dong-A ST
11.7.1 Dong-A ST Company Details
11.7.2 Company Description and Business Overview
11.7.3 Sales, Revenue and Market Share of Erectile Dysfunction Drugs
11.7.4 Erectile Dysfunction Drugs Product Introduction
11.7.5 Dong-A ST Recent Development
11.8 Metuchen Pharma
11.8.1 Metuchen Pharma Company Details
11.8.2 Company Description and Business Overview
11.8.3 Sales, Revenue and Market Share of Erectile Dysfunction Drugs
11.8.4 Erectile Dysfunction Drugs Product Introduction
11.8.5 Metuchen Pharma Recent Development
11.9 Seoul Pharma
11.9.1 Seoul Pharma Company Details
11.9.2 Company Description and Business Overview
11.9.3 Sales, Revenue and Market Share of Erectile Dysfunction Drugs
11.9.4 Erectile Dysfunction Drugs Product Introduction
11.9.5 Seoul Pharma Recent Development
11.10 CSBIO.
11.10.1 CSBIO. Company Details
11.10.2 Company Description and Business Overview
11.10.3 Sales, Revenue and Market Share of Erectile Dysfunction Drugs
11.10.4 Erectile Dysfunction Drugs Product Introduction
11.10.5 CSBIO. Recent Development

12 Value Chain and Sales Channels Analysis
12.1 Value Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Erectile Dysfunction Drugs Sales Channels
12.2.2 Erectile Dysfunction Drugs Distributors
12.3 Erectile Dysfunction Drugs Customers

13 Market Forecast
13.1 Global Erectile Dysfunction Drugs Sales and Revenue Forecast 2019-2025
13.2 Global Erectile Dysfunction Drugs Sales Forecast by Type
13.3 Global Erectile Dysfunction Drugs Sales Forecast by Application
13.4 Erectile Dysfunction Drugs Forecast by Regions
13.4.1 Global Erectile Dysfunction Drugs Sales Forecast by Regions 2019-2025
13.4.2 Global Erectile Dysfunction Drugs Revenue Forecast by Regions 2019-2025
13.5 North America Market Forecast
13.5.1 North America Erectile Dysfunction Drugs Forecast by Countries 2019-2025
13.5.2 United States
13.5.3 Canada
13.5.4 Mexico
13.6 Europe Market Forecast
13.6.1 Europe Erectile Dysfunction Drugs Forecast by Countries 2019-2025
13.6.2 Germany
13.6.3 France
13.6.4 UK
13.6.5 Italy
13.6.6 Russia
13.7 Asia Pacific Market Forecast
13.7.1 Asia Pacific Erectile Dysfunction Drugs Sales Forecast by Regions 2019-2025
13.7.2 China
13.7.3 Japan
13.7.4 South Korea
13.7.5 India
13.7.6 Australia
13.7.7 Indonesia
13.7.8 Thailand
13.7.9 Malaysia
13.7.10 Philippines
13.7.11 Vietnam
13.8 Central & South America Market Forecast
13.8.1 Central & South America Erectile Dysfunction Drugs Sales Forecast by Countries 2019-2025
13.8.2 Brazil
13.9 Middle East and Africa Market Forecast
13.9.1 Middle East and Africa Erectile Dysfunction Drugs Sales Forecast by Countries 2019-2025
13.9.2 Turkey
13.9.3 GCC Countries
13.9.4 Egypt
13.9.5 South Africa

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

List of Tables and Figures

Figure Erectile Dysfunction Drugs Product Picture
Table Erectile Dysfunction Drugs Key Market Segments
Table Major Manufacturers Erectile Dysfunction Drugs Covered in This Report
Table Global Erectile Dysfunction Drugs Market Size Growth Rate by Type 2019-2025 (M Pill) & (Million US$)
Figure Global Erectile Dysfunction Drugs Sales Market Shar by Type 2014-2025
Figure Sildenafil Figures
Table Major Manufacturers of Sildenafil
Figure Tadalafil Figures
Table Major Manufacturers of Tadalafil
Figure Others Figures
Table Major Manufacturers of Others
Table Global Erectile Dysfunction Drugs Market Share by Application 2019-2025 (M Pill)
Figure Hospital Pharmacies Use Case
Figure Private Clinics Use Case
Figure Retail Pharmacies Use Case
Figure E-Commerce (B2B) Use Case
Figure E-Commerce (B2C) Use Case
Figure Erectile Dysfunction Drugs Report Years Considered
Figure Global Erectile Dysfunction Drugs Market Size 2014-2025 (Million US$)
Figure Global Erectile Dysfunction Drugs Sales 2014-2019 (M Pill)
Table Global Erectile Dysfunction Drugs Market Size by Regions 2014-2019 (M Pill) & (Million US$)
Table Global Erectile Dysfunction Drugs Sales by Regions 2014-2019 (M Pill)
Table Global Erectile Dysfunction Drugs Sales Market Share by Regions 2014-2019
Figure Global Erectile Dysfunction Drugs Sales Market Share by Regions 2014-2019
Figure Global Erectile Dysfunction Drugs Sales Market Share by Regions in 2018
Table Global Erectile Dysfunction Drugs Revenue by Regions 2014-2019 (Million US$)
Table Global Erectile Dysfunction Drugs Revenue Market Share by Regions 2014-2019
Figure Global Erectile Dysfunction Drugs Revenue Market Share by Regions 2014-2019
Figure Global Erectile Dysfunction Drugs Revenue Market Share by Regions in 2018
Table Market Top Trends
Table Global Erectile Dysfunction Drugs Sales by Manufacturers (2014-2019) (M Pill)
Table Global Erectile Dysfunction Drugs Sales Share by Manufacturers (2014-2019)
Figure Global Erectile Dysfunction Drugs Sales Share by Manufacturers in 2018
Table Erectile Dysfunction Drugs Revenue by Manufacturers (2014-2019) (Million USD)
Table Erectile Dysfunction Drugs Revenue Share by Manufacturers (2014-2019)
Figure Erectile Dysfunction Drugs Value Share by Manufacturers in 2018
Table Global Erectile Dysfunction Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Erectile Dysfunction Drugs Price (2014-2019) (USD/Pill)
Table Key Manufacturers Erectile Dysfunction Drugs Plants/Factories Distribution
Table Key Manufacturers Erectile Dysfunction Drugs Area Served
Table Date of Key Manufacturers Enter into Erectile Dysfunction Drugs Market
Table Key Manufacturers Erectile Dysfunction Drugs Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global Sildenafil Sales an目录输出!D Revenue (2014-2019) (M Pill) & (Million US$)
Table Global Tadalafil Sales an目录输出!D Revenue (2014-2019) (M Pill) & (Million US$)
Table Global Others Sales an目录输出!D Revenue (2014-2019) (M Pill) & (Million US$)
Table Global Erectile Dysfunction Drugs Sales by Type (2014-2019) (M Pill)
Table Global Erectile Dysfunction Drugs Sales Share by Type (2014-2019)
Figure Global Erectile Dysfunction Drugs Sales Market Share by Type (2014-2019)
Figure Global Erectile Dysfunction Drugs Sales Market Share by Type in 2018
Table Global Erectile Dysfunction Drugs Revenue by Type (2014-2019) (Million US$)
Table Global Erectile Dysfunction Drugs Revenue Share by Type (2014-2019)
Figure Global Erectile Dysfunction Drugs Revenue Market Share by Type (2014-2019)
Figure Global Erectile Dysfunction Drugs Revenue Market Share by Type in 2018
Table Erectile Dysfunction Drugs Price by Type 2014-2019 (USD/Pill)
Table Global Erectile Dysfunction Drugs Sales by Application (2014-2019) (M Pill)
Table Global Erectile Dysfunction Drugs Sales Share by Application (2014-2019)
Figure Global Sales Erectile Dysfunction Drugs Market Share by Application (2014-2019)
Figure Global Sales Erectile Dysfunction Drugs Market Share by Application in 2018
Figure North America Erectile Dysfunction Drugs Sales Growth Rate 2014-2019 (M Pill)
Figure North America Erectile Dysfunction Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table North America Erectile Dysfunction Drugs Sales by Company (2014-2019) (M Pill)
Table North America Erectile Dysfunction Drugs Sales Market Share by Company (2014-2019)
Figure North America Erectile Dysfunction Drugs Sales Market Share by Company in 2018
Table North America Erectile Dysfunction Drugs Sales by Type (2014-2019) (M Pill)
Table North America Erectile Dysfunction Drugs Sales Market Share by Type (2014-2019)
Figure North America Erectile Dysfunction Drugs Market Share by Type in 2018
Table North America Erectile Dysfunction Drugs Sales by Application (2014-2019) (M Pill)
Table North America Erectile Dysfunction Drugs Sales Market Share by Application (2014-2019)
Figure North America Erectile Dysfunction Drugs Market Share by Application in 2018
Table North America Erectile Dysfunction Drugs Sales by Countries (2014-2019) (M Pill)
Table North America Erectile Dysfunction Drugs Sales Market Share by Countries (2014-2019)
Figure North America Erectile Dysfunction Drugs Sales Market Share by Countries in 2018
Table North America Erectile Dysfunction Drugs Revenue by Countries (2014-2019) (Million US$)
Table North America Erectile Dysfunction Drugs Revenue Market Share by Countries (2014-2019)
Figure North America Erectile Dysfunction Drugs Revenue Market Share by Countries in 2018
Figure United States Erectile Dysfunction Drugs Sales Growth Rate (2014-2019) (M Pill)
Figure Canada Erectile Dysfunction Drugs Sales Growth Rate (2014-2019) (M Pill)
Figure Mexico Erectile Dysfunction Drugs Sales Growth Rate (2014-2019) (M Pill)
Figure Europe Erectile Dysfunction Drugs Sales Growth Rate 2014-2019 (M Pill)
Figure Europe Erectile Dysfunction Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Erectile Dysfunction Drugs Sales by Company (2014-2019) (M Pill)
Table Europe Erectile Dysfunction Drugs Sales Market Share by Company (2014-2019)
Figure Europe Erectile Dysfunction Drugs Sales Market Share by Company in 2018
Table Europe Erectile Dysfunction Drugs Sales by Type (2014-2019) (M Pill)
Table Europe Erectile Dysfunction Drugs Sales Market Share by Type (2014-2019)
Figure Europe Erectile Dysfunction Drugs Sales Market Share by Type in 2018
Table Europe Erectile Dysfunction Drugs Sales by Application (2014-2019) (M Pill)
Table Europe Erectile Dysfunction Drugs Sales Market Share by Application (2014-2019)
Figure Europe Erectile Dysfunction Drugs Sales Market Share by Application in 2018
Table Europe Erectile Dysfunction Drugs Sales by Countries (2014-2019) (M Pill)
Table Europe Erectile Dysfunction Drugs Sales Market Share by Countries (2014-2019)
Figure Europe Erectile Dysfunction Drugs Sales Market Share by Countries in 2018
Table Europe Erectile Dysfunction Drugs Revenue by Countries (2014-2019) (Million US$)
Table Europe Erectile Dysfunction Drugs Revenue Market Share by Countries (2014-2019)
Figure Europe Erectile Dysfunction Drugs Revenue Market Share by Countries in 2018
Figure Germany Erectile Dysfunction Drugs Sales Growth Rate (2014-2019) (M Pill)
Figure France Erectile Dysfunction Drugs Sales Growth Rate (2014-2019) (M Pill)
Figure UK Erectile Dysfunction Drugs Sales Growth Rate (2014-2019) (M Pill)
Figure Italy Erectile Dysfunction Drugs Sales Growth Rate (2014-2019) (M Pill)
Figure Russia Erectile Dysfunction Drugs Sales Growth Rate (2014-2019) (M Pill)
Figure Asia Pacific Erectile Dysfunction Drugs Sales Growth Rate 2014-2019 (M Pill)
Figure Asia Pacific Erectile Dysfunction Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Erectile Dysfunction Drugs Sales by Regions (2014-2019) (M Pill)
Table Asia Pacific Erectile Dysfunction Drugs Sales Market Share by Regions (2014-2019)
Figure Asia Pacific Erectile Dysfunction Drugs Sales Market Share by Regions in 2018
Table Asia Pacific Erectile Dysfunction Drugs Sales by Type (2014-2019) (M Pill)
Table Asia Pacific Erectile Dysfunction Drugs Sales Market Share by Type (2014-2019)
Figure Asia Pacific Erectile Dysfunction Drugs Market Share by Type in 2018
Table Asia Pacific Erectile Dysfunction Drugs Sales by Application (2014-2019) (M Pill)
Table Asia Pacific Erectile Dysfunction Drugs Sales Market Share by Application (2014-2019)
Figure Asia Pacific Erectile Dysfunction Drugs Market Share by Application in 2018
Table Asia Pacific Erectile Dysfunction Drugs Sales by Countries (2014-2019) (M Pill)
Table Asia Pacific Erectile Dysfunction Drugs Sales Market Share by Regions (2014-2019)
Figure Asia Pacific Erectile Dysfunction Drugs Sales Market Share by Regions in 2018
Table Asia Pacific Erectile Dysfunction Drugs Revenue by Regions (2014-2019) (Million US$)
Table Asia Pacific Erectile Dysfunction Drugs Revenue Market Share by Regions (2014-2019)
Figure Asia Pacific Erectile Dysfunction Drugs Revenue Market Share by Regions in 2018
Figure China Erectile Dysfunction Drugs Sales Growth Rate (2014-2019) (M Pill)
Figure China Erectile Dysfunction Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Erectile Dysfunction Drugs Sales Growth Rate (2014-2019) (M Pill)
Figure Japan Erectile Dysfunction Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Erectile Dysfunction Drugs Sales Growth Rate (2014-2019) (M Pill)
Figure Korea Erectile Dysfunction Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure India Erectile Dysfunction Drugs Sales Growth Rate (2014-2019) (M Pill)
Figure India Erectile Dysfunction Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Erectile Dysfunction Drugs Sales Growth Rate (2014-2019) (M Pill)
Figure Australia Erectile Dysfunction Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Erectile Dysfunction Drugs Sales Growth Rate (2014-2019) (M Pill)
Figure Indonesia Erectile Dysfunction Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Erectile Dysfunction Drugs Sales Growth Rate (2014-2019) (M Pill)
Figure Malaysia Erectile Dysfunction Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Erectile Dysfunction Drugs Sales Growth Rate (2014-2019) (M Pill)
Figure Philippines Erectile Dysfunction Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Erectile Dysfunction Drugs Sales Growth Rate (2014-2019) (M Pill)
Figure Thailand Erectile Dysfunction Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Erectile Dysfunction Drugs Sales Growth Rate (2014-2019) (M Pill)
Figure Vietnam Erectile Dysfunction Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Central & South America Erectile Dysfunction Drugs Sales Growth Rate 2014-2019 (M Pill)
Figure Central & South America Erectile Dysfunction Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Erectile Dysfunction Drugs Sales by Company (2014-2019) (M Pill)
Table Central & South America Erectile Dysfunction Drugs Sales Market Share by Company (2014-2019)
Figure Central & South America Erectile Dysfunction Drugs Sales Market Share by Company in 2018
Table Central & South America Erectile Dysfunction Drugs Sales by Type (2014-2019) (M Pill)
Table Central & South America Erectile Dysfunction Drugs Sales Market Share by Type (2014-2019)
Figure Central & South America Erectile Dysfunction Drugs Market Share by Type in 2018
Table Central & South America Erectile Dysfunction Drugs Sales by Application (2014-2019) (M Pill)
Table Central & South America Erectile Dysfunction Drugs Sales Market Share by Application (2014-2019)
Figure Central & South America Erectile Dysfunction Drugs Market Share by Application in 2018
Table Central & South America Erectile Dysfunction Drugs Sales by Countries (2014-2019) (M Pill)
Table Central & South America Erectile Dysfunction Drugs Sales Market Share by Countries (2014-2019)
Figure Central & South America Erectile Dysfunction Drugs Sales Market Share by Countries in 2018
Table Central & South America Erectile Dysfunction Drugs Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Erectile Dysfunction Drugs Revenue Market Share by Countries (2014-2019)
Figure Central & South America Erectile Dysfunction Drugs Revenue Market Share by Countries in 2018
Figure Brazil Erectile Dysfunction Drugs Sales Growth Rate (2014-2019) (M Pill)
Figure Brazil Erectile Dysfunction Drugs Revenue Growth Rate (2014-2019) (M Pill)
Figure Middle East and Africa Erectile Dysfunction Drugs Sales Growth Rate 2014-2019 (M Pill)
Figure Middle East and Africa Erectile Dysfunction Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Erectile Dysfunction Drugs Sales by Type (2014-2019) (M Pill)
Table Middle East and Africa Erectile Dysfunction Drugs Sales Market Share by Type (2014-2019)
Figure Middle East and Africa Erectile Dysfunction Drugs Sales Market Share by Type in 2018
Table Middle East and Africa Erectile Dysfunction Drugs Sales by Application (2014-2019) (M Pill)
Table Middle East and Africa Erectile Dysfunction Drugs Sales Market Share by Application (2014-2019)
Figure Middle East and Africa Erectile Dysfunction Drugs Sales Market Share by Application in 2018
Table Middle East and Africa Erectile Dysfunction Drugs Sales by Countries (2014-2019) (M Pill)
Table Middle East and Africa Erectile Dysfunction Drugs Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Erectile Dysfunction Drugs Sales Market Share by Countries in 2018
Table Middle East and Africa Erectile Dysfunction Drugs Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Erectile Dysfunction Drugs Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Erectile Dysfunction Drugs Revenue Market Share by Countries in 2018
Figure GCC Countries Erectile Dysfunction Drugs Sales Growth Rate (2014-2019) (M Pill)
Figure GCC Countries Erectile Dysfunction Drugs Revenue Growth Rate (2014-2019) (M Pill)
Figure Egypt Erectile Dysfunction Drugs Sales Growth Rate (2014-2019) (M Pill)
Figure Egypt Erectile Dysfunction Drugs Revenue Growth Rate (2014-2019) (M Pill)
Figure South Africa Erectile Dysfunction Drugs Sales Growth Rate (2014-2019) (M Pill)
Figure South Africa Erectile Dysfunction Drugs Revenue Growth Rate (2014-2019) (M Pill)
Table Eli Lilly Company Details
Table Eli Lilly Description and Business Overview
Table Eli Lilly Erectile Dysfunction Drugs Sales (M Pill), Revenue (Million US$), Price (USD/Pill) and Gross Margin (2014-2019)
Table Eli Lilly Erectile Dysfunction Drugs Sales Growth Rate (2014-2019)
Table Eli Lilly Erectile Dysfunction Drugs Sales Market Share in Global Market
Table Eli Lilly Recent Development
Table Pfizer Company Details
Table Pfizer Description and Business Overview
Table Pfizer Erectile Dysfunction Drugs Sales (M Pill), Revenue (Million US$), Price (USD/Pill) and Gross Margin (2014-2019)
Table Pfizer Erectile Dysfunction Drugs Sales Growth Rate (2014-2019)
Table Pfizer Erectile Dysfunction Drugs Sales Market Share in Global Market
Table Pfizer Recent Development
Table Bayer Company Details
Table Bayer Description and Business Overview
Table Bayer Erectile Dysfunction Drugs Sales (M Pill), Revenue (Million US$), Price (USD/Pill) and Gross Margin (2014-2019)
Table Bayer Erectile Dysfunction Drugs Sales Growth Rate (2014-2019)
Table Bayer Erectile Dysfunction Drugs Sales Market Share in Global Market
Table Bayer Recent Development
Table BaiYunShan General Factory Company Details
Table BaiYunShan General Factory Description and Business Overview
Table BaiYunShan General Factory Erectile Dysfunction Drugs Sales (M Pill), Revenue (Million US$), Price (USD/Pill) and Gross Margin (2014-2019)
Table BaiYunShan General Factory Erectile Dysfunction Drugs Sales Growth Rate (2014-2019)
Table BaiYunShan General Factory Erectile Dysfunction Drugs Sales Market Share in Global Market
Table BaiYunShan General Factory Recent Development
Table S.K. Chemicals Company Details
Table S.K. Chemicals Description and Business Overview
Table S.K. Chemicals Erectile Dysfunction Drugs Sales (M Pill), Revenue (Million US$), Price (USD/Pill) and Gross Margin (2014-2019)
Table S.K. Chemicals Erectile Dysfunction Drugs Sales Growth Rate (2014-2019)
Table S.K. Chemicals Erectile Dysfunction Drugs Sales Market Share in Global Market
Table S.K. Chemicals Recent Development
Table Teva Pharma Company Details
Table Teva Pharma Description and Business Overview
Table Teva Pharma Erectile Dysfunction Drugs Sales (M Pill), Revenue (Million US$), Price (USD/Pill) and Gross Margin (2014-2019)
Table Teva Pharma Erectile Dysfunction Drugs Sales Growth Rate (2014-2019)
Table Teva Pharma Erectile Dysfunction Drugs Sales Market Share in Global Market
Table Teva Pharma Recent Development
Table Dong-A ST Company Details
Table Dong-A ST Description and Business Overview
Table Dong-A ST Erectile Dysfunction Drugs Sales (M Pill), Revenue (Million US$), Price (USD/Pill) and Gross Margin (2014-2019)
Table Dong-A ST Erectile Dysfunction Drugs Sales Growth Rate (2014-2019)
Table Dong-A ST Erectile Dysfunction Drugs Sales Market Share in Global Market
Table Dong-A ST Recent Development
Table Metuchen Pharma Company Details
Table Metuchen Pharma Description and Business Overview
Table Metuchen Pharma Erectile Dysfunction Drugs Sales (M Pill), Revenue (Million US$), Price (USD/Pill) and Gross Margin (2014-2019)
Table Metuchen Pharma Erectile Dysfunction Drugs Sales Growth Rate (2014-2019)
Table Metuchen Pharma Erectile Dysfunction Drugs Sales Market Share in Global Market
Table Metuchen Pharma Recent Development
Table Seoul Pharma Company Details
Table Seoul Pharma Description and Business Overview
Table Seoul Pharma Erectile Dysfunction Drugs Sales (M Pill), Revenue (Million US$), Price (USD/Pill) and Gross Margin (2014-2019)
Table Seoul Pharma Erectile Dysfunction Drugs Sales Growth Rate (2014-2019)
Table Seoul Pharma Erectile Dysfunction Drugs Sales Market Share in Global Market
Table Seoul Pharma Recent Development
Table CSBIO. Company Details
Table CSBIO. Description and Business Overview
Table CSBIO. Erectile Dysfunction Drugs Sales (M Pill), Revenue (Million US$), Price (USD/Pill) and Gross Margin (2014-2019)
Table CSBIO. Erectile Dysfunction Drugs Sales Growth Rate (2014-2019)
Table CSBIO. Erectile Dysfunction Drugs Sales Market Share in Global Market
Table CSBIO. Recent Development
Figure Erectile Dysfunction Drugs Value Chain
Table Erectile Dysfunction Drugs Distributors List
Table Erectile Dysfunction Drugs Customers List
Table Global Erectile Dysfunction Drugs Sales Forecast 2019-2025 (M Pill) & (Million US$)
Figure Global Erectile Dysfunction Drugs Sales Forecast 2019-2025 (M Pill)
Figure Global Erectile Dysfunction Drugs Revenue Forecast 2019-2025 (Million US$)
Table Global Erectile Dysfunction Drugs Sales Forecast by Type 2019-2025 (M Pill)
Figure Global Erectile Dysfunction Drugs Sales Forecast by Type 2019-2025 (M Pill)
Figure Global Erectile Dysfunction Drugs Sales Market Share Forecast by Type 2019-2025
Table Global Erectile Dysfunction Drugs Sales Forecast by Application 2019-2025 (M Pill)
Figure Global Erectile Dysfunction Drugs Sales Forecast by Application 2019-2025 (M Pill)
Figure Global Erectile Dysfunction Drugs Sales Market Share Forecast by Application 2019-2025
Table Global Erectile Dysfunction Drugs Sales Forecast by Regions 2019-2025 (M Pill)
Figure Global Erectile Dysfunction Drugs Sales Forecast by Regions 2019-2025 (M Pill)
Figure Global Erectile Dysfunction Drugs Sales Market Share Forecast by Regions 2019-2025
Table Global Erectile Dysfunction Drugs Revenue Forecast by Regions 2019-2025 (Million US$)
Figure Global Erectile Dysfunction Drugs Revenue Forecast by Regions 2019-2025 (Million US$)
Figure Global Erectile Dysfunction Drugs Revenue Market Share Forecast by Regions 2019-2025
Table North America Erectile Dysfunction Drugs Sales Forecast by Countries 2019-2025 (M Pill)
Table North America Erectile Dysfunction Drugs Sales Market Share Forecast by Countries 2019-2025
Table North America Erectile Dysfunction Drugs Revenue Forecast by Countries 2019-2025 (Million US$)
Table North America Erectile Dysfunction Drugs Revenue Market Share Forecast by Countries 2019-2025
Figure United States Erectile Dysfunction Drugs Sales Forecast 2019-2025 (M Pill)
Figure Canada Erectile Dysfunction Drugs Sales Forecast 2019-2025 (M Pill)
Figure Mexico Erectile Dysfunction Drugs Sales Forecast 2019-2025 (M Pill)
Table Europe Erectile Dysfunction Drugs Sales Forecast by Countries 2019-2025 (M Pill)
Table Europe Erectile Dysfunction Drugs Sales Market Share Forecast by Countries 2019-2025
Table Europe Erectile Dysfunction Drugs Revenue Forecast by Countries 2019-2025 (Million US$)
Table Europe Erectile Dysfunction Drugs Revenue Market Share Forecast by Countries 2019-2025
Figure Germany Erectile Dysfunction Drugs Sales Forecast 2019-2025 (M Pill)
Figure France Erectile Dysfunction Drugs Sales Forecast 2019-2025 (M Pill)
Figure UK Erectile Dysfunction Drugs Sales Forecast 2019-2025 (M Pill)
Figure Italy Erectile Dysfunction Drugs Sales Forecast 2019-2025 (M Pill)
Figure Russia Erectile Dysfunction Drugs Sales Forecast 2019-2025 (M Pill)
Table Asia Pacific Erectile Dysfunction Drugs Sales Forecast by Regions 2019-2025 (M Pill)
Table Asia Pacific Erectile Dysfunction Drugs Sales Market Share Forecast by Regions 2019-2025
Table Asia Pacific Erectile Dysfunction Drugs Revenue Forecast by Regions 2019-2025 (Million US$)
Table Asia Pacific Erectile Dysfunction Drugs Revenue Market Share Forecast by Regions 2019-2025
Figure China Erectile Dysfunction Drugs Sales Forecast 2019-2025 (M Pill)
Figure Japan Erectile Dysfunction Drugs Sales Forecast 2019-2025 (M Pill)
Figure South Korea Erectile Dysfunction Drugs Sales Forecast 2019-2025 (M Pill)
Figure India Erectile Dysfunction Drugs Sales Forecast 2019-2025 (M Pill)
Figure Australia Erectile Dysfunction Drugs Sales Forecast 2019-2025 (M Pill)
Figure Indonesia Erectile Dysfunction Drugs Sales Forecast 2019-2025 (M Pill)
Figure Thailand Erectile Dysfunction Drugs Sales Forecast 2019-2025 (M Pill)
Figure Malaysia Erectile Dysfunction Drugs Sales Forecast 2019-2025 (M Pill)
Figure Philippines Erectile Dysfunction Drugs Sales Forecast 2019-2025 (M Pill)
Figure Vietnam Erectile Dysfunction Drugs Sales Forecast 2019-2025 (M Pill)
Table Central & South America Erectile Dysfunction Drugs Sales Forecast by Countries 2019-2025 (M Pill)
Table Central & South America Erectile Dysfunction Drugs Sales Market Share Forecast by Countries 2019-2025
Table Central & South America Erectile Dysfunction Drugs Revenue Forecast by Countries 2019-2025 (Million US$)
Table Central & South America Erectile Dysfunction Drugs Revenue Market Share Forecast by Countries 2019-2025
Figure Brazil Erectile Dysfunction Drugs Sales Forecast 2019-2025 (M Pill)
Table Middle East and Africa Erectile Dysfunction Drugs Sales Forecast by Regions 2019-2025 (M Pill)
Table Middle East and Africa Erectile Dysfunction Drugs Sales Market Share Forecast by Regions 2019-2025
Table Middle East and Africa Erectile Dysfunction Drugs Revenue Forecast by Regions 2019-2025 (Million US$)
Table Middle East and Africa Erectile Dysfunction Drugs Revenue Market Share Forecast by Regions 2019-2025
Figure Turkey Erectile Dysfunction Drugs Sales Forecast 2019-2025 (M Pill)
Figure GCC Countries Erectile Dysfunction Drugs Sales Forecast 2019-2025 (M Pill)
Figure Egypt Erectile Dysfunction Drugs Sales Forecast 2019-2025 (M Pill)
Figure South Africa Erectile Dysfunction Drugs Sales Forecast 2019-2025 (M Pill)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources